Global

Elsevier,

Journal of Integrative Agriculture, Volume 21, April 2022

Using agronomic experiment data from 62 studies between 1987 and 2021, we employ a meta-analysis to analyze the factors contributing to the heterogeneous effects of wastewater irrigation on crop yield.
Elsevier,

Biochimica et Biophysica Acta - Molecular Basis of Disease, Volume 1868, 1 April 2022

 A schematic diagram of the protein structure of Fibrocystin (FPC) and DZIP1L
ARPKD is a rare disease. This review explores the genetics of ARPKD and is accompanied by a short video by the author with a summary of the article.
Cross-sectional and longitudinal soluble TREM2 levels in CSF according to estimated years to symptom onset (EYO) in carriers and non-carriers of pathogenic variants.
An article on Alzheimer's disease progression, in the context of SDG 3, focusing specifically on the dynamics of soluble TREM2 and its association with amyloid and tau markers, neuroimaging features, and cognition.
In vitro and in vivo studies showed that melatonin therapy is effective against AD. The emerging novel melatonin-based therapies are potential treatment options in AD.
Elsevier,

Kanski's Synopsis of Clinical Ophthalmology (Fourth edition)
2023, Pages 289-303

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing insight on a group of inherited disorders that have an effect on the RPE-photoreceptor complex and choriocapillaris, causing a range of symptoms and in many cases gradual visual loss.
Hand holding paper globe cutout
ISO 26000 provides social responsibility guidance to organisations around the world to assist them in contributing to global sustainable development. ISO 26000 contributes to every one of the 17 SDGs but is particularly influential to SDG 8, Decent Work and Economic Growth.
Elsevier,

Animal Behaviour, Volume 186, April 2022, Pages 151-177

The authors investigate whether applying multiple welfare indicators’ and triangulating them can lead to converged and corroborating evidence of welfare, or whether the indicators' contradict one another.
This chapter briefly reviews the history of ketamine, explores proposed mechanisms of action, outlines data pertaining to efficacy and safety, and considers “real-world” usage and the challenges to implementation.
This chapter clearly defines “treatment-resistant depression (TRD)” and “difficult-to-treat depression (DTD)" to help clinicians to understand how to treat patients with depression.

Pages